Oppenheimer
12.02.2019 | Public Offering
Adv. Shy Baranov and other attorneys represented Oppenheimer and Co., as underwriter’s Israel counsel in a $30 million initial public offering in the U.S. of Anchiano’s ADSs. Anchiano has been listed on the TASE and since its U.S. IPO is also listed for trading on Nasdaq.
Anchiano is a pivotal-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapies to treat cancer in areas of unmet need.